Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE)
Colaneri et al., Microorganisms, doi:10.3390/microorganisms8050695
https://c19early.org/colaneri2.html